Clinical Trials for Diffuse Large B-cell Lymphoma (DLBCL)

Find clinical trials for diffuse large b-cell lymphoma (dlbcl). Discover research opportunities and treatment options in your area.

8 Active Trials Found

Showing 8 trials on this page

Page 1 of 1

Study to Evaluate Efficacy and Safety of Oral Abexinostat in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

NCT ID: NCT03936153

This clinical trial is looking at a new oral medication called abexinostat to see how well it works and how safe it is for people with a type of blood cancer called diffuse large B-cell lymphoma (D...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, , China, Shanghai, , China +24 more

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

NCT ID: NCT04830137

This clinical trial is investigating a new treatment called NX-2127 for adults with certain types of advanced B-cell cancers, such as Chronic Lymphocytic Leukemia (CLL) and various types of lymphom...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seattle, Washington, United States, New York, New York, United States +15 more

Study of Pomalidomide Combination with Rituximab and Anti-PD-1 Antibody （PPR） in Third or Later Line Therapy of DLBCL

NCT ID: NCT06832228

This clinical trial is looking at a new treatment approach for patients with diffuse large B-cell lymphoma (DLBCL), which is a type of blood cancer. The study is testing a combination of three medi...

Recruiting

Phase: NA Type: interventional Locations: Hangzhou, Zhejiang, China

Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms

NCT ID: NCT06043011

The RUBIN trial is focused on collecting important information about various blood cancers, including Chronic Lymphocytic Leukemia (CLL) and several types of lymphoma. The goal is to create a natio...

Recruiting

Type: observational Locations: Freiburg, , Germany

Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas

NCT ID: NCT05583149

This clinical trial is investigating the combination of two treatments, acalabrutinib and lisocabtagene maraleucel (liso-cel), for adults with aggressive B-cell lymphomas that have not improved aft...

Recruiting

Phase: PHASE2 Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States +1 more

A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML

NCT ID: NCT03547115

This clinical trial is studying a medication called voruciclib, both on its own and in combination with another drug called venetoclax, to see how safe and effective they are for patients with cert...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States, Chicago, Illinois, United States +10 more

Zanubrutinib in Maintenance Therapy of DLBCL Patients With Initial Remission

NCT ID: NCT05596097

This clinical trial is investigating a treatment called zanubrutinib for patients with diffuse large B-cell lymphoma (DLBCL) who are in initial remission after receiving standard chemotherapy. The ...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Lanzhou, Gansu, China

Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma Patients

NCT ID: NCT04836507

This clinical trial is testing a new treatment called CRC01 for adults with certain types of large B-cell lymphomas, which are cancers of the lymphatic system that have come back or did not respond...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seoul, , Korea, Republic Of

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions